22.05.2018 Views

antibioticsbooks

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

142 PART 2 Antibacterial Drugs<br />

Spectrum<br />

Good: many GNRs, including multidrug resistant<br />

Acinetobacter baumannii, Pseudomonas aeruginosa,<br />

and Klebsiella pneumoniae<br />

Moderate: Stenotrophomonas maltophilia<br />

Poor: all Gram-positive organisms, anaerobes,<br />

Proteus, Providencia, Burkholderia, Serratia,<br />

Gram-negative cocci<br />

Adverse Effects<br />

Renal: The most common adverse effect is nephrotoxicity<br />

due to acute tubular necrosis. Acute<br />

kidney injury commonly occurs in clinical use,<br />

though the incidence of polymyxin-induced toxicity<br />

is hard to estimate because most recent<br />

studies of polymyxins are noncomparative<br />

evaluations of last-line indications in very ill<br />

patients.<br />

Neurological: Neurotoxicity is less common. It can<br />

manifest as dizziness, weakness, paresthesias,<br />

or mental status changes. Neuromuscular blockade<br />

can also occur and may lead to fatal respiratory<br />

arrest.<br />

■■<br />

Important Facts<br />

• Colistin and polymyxin B are very similar<br />

drugs. Colistin may be more active, but to be<br />

given systemically it is administered as colistimethate<br />

sodium. Colistimethate is then<br />

converted into active colistin in the body.<br />

Colistimethate is renally cleared, and only<br />

the proportion that is not cleared is converted<br />

to colistin. It is dosed as milligrams of active<br />

colistin (~400 mg colistimethate 5 150 mg of

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!